Fig. 1

The entire framework and detailed weighted values for each of the GOHI-AMR structural indicators. The complete name and abbreviation of all indicators among three hierarchical indicators system of GOHI-AMR, consisting of 5 key indicators, 17 indicators, and 49 sub-indicators as following: 1. ASS (key indicator): AMR surveillance system. 1.1AMC (indicator): Antimicrobial consumption in both human and animals; 1.1.1 ACH (sub-indicator): Antimicrobial consumption in human; 1.1.2 ACA (sub-indicator): Antimicrobial consumption in animals; 1.1.3 PTU (sub-indicator): Pesticide Use; 1.2 AMU (indicator): Antimicrobial resistance status in human, animals, and food; 1.2.1 AMH (sub-indicator): AMR in human; 1.2.2AMA (sub-indicator): AMR in animals; 1.2.3 AMF: AMR in food; 1.3 EAR (indicator): Environmental surveillance system; 1.3.1 ESS: Environmental surveillance system; 2. LNC (key indicator): AMR laboratory network and coordination capacity. 2.1 NTC (indicator): National AMR capacity; 2.1.1 NRL (sub-indicator): National reference laboratory; 2.1.2 EIL (sub-indicator): Effective integration of laboratories; 2.2 TLV (indicator): Technical promotion score in AMR; 2.2.1 MSW (sub-indicator): multi-sector working on AMR; 2.2.2 SHL (sub-indicator): Standardization and harmonization of laboratories; 2.2.3 RDT: Relevance of diagnostic techniques; 2.2.4 LDM (sub-indicator): Technical level of data management; 2.3 NTP (indicator): National action plan formulations; 2.3.1 NPP (sub-indicator): National plan for AMR priority pathogens; 2.3.2 NAP (sub-indicator): National action plan on AMR; 2.3.3 LOE (sub-indicator): National action plan on AMR linked to any other existing action plans; 2.3.4 PAP (sub-indicator): Publishment of action plan; 3. ACO (key indicator): Antimicrobial control and optimization. 3.1 NLA (indicator): National law(s) for antibiotic use; 3.1.1 LUH (sub-indicator): National law(s) for the use of antibiotics in humans; 3.1.2. LUA (sub-indicator): National law(s) for antibiotic use in animals; 3.1.3. NLM: (sub-indicator) National law(s) on marketing of pesticides; 3.1.4. NLP (sub-indicator): National law(s) on prohibits the use of antibiotics; 3.2 AUO (indicator): Optimization of antimicrobial use; 3.2.1 OUH (sub-indicator): Optimizing antimicrobial use in human health; 3.2.2 OUA (sub-indicator): Optimizing antimicrobial use in animal health; 3.2.3 OAP (sub-indicator): Optimizing antimicrobial pesticide use in plants; 3.3 AUC (indicator): Interruption capacity of antimicrobial resistance transmission; 3.3.1 IPC (sub-indicator): Infection Prevention and Control in human; 3.3.2 RTA (sub-indicator): Reduce transmission of AMR in animal production; 3.3.3 RTF (sub-indicator): Reduce transmission of AMR in food processing; 4.IAU (key indicator): Improve awareness and understanding; 4.1PHA (indicator): Raising awareness and understanding; 4.1.1 RAU (sub-indicator): Raising awareness and understanding; 4.2 PFT (indicator): Professional training activities in multi-sectors; 4.2.1 THS (sub-indicator): Training in the human health sector; 4.2.2 TVS (sub-indicator): Training in the veterinary sector; 4.2.3TFS (sub-indicator): Training in the farming sector; 4.2.4 PSV (sub-indicator): Progress with strengthening veterinary services; 5.ARR (key indicator): Antimicrobial resistance rate for important antibiotics. 5.1 CAR (indicator): Carbapenems-resistents for multi-specise; 5.1.1 CR-KPN (sub-indicator): Carbapenems-resistent Klebsiella pneumoniae; 5.1.2 CR-ABA (sub-indicator): Carbapenems-resistent Acinetobacter baumannii; 5.1.3 CR-ECO (sub-indicator): Carbapenems-resistent Escherichia coli; 5.1.4CR-PAE (sub-indicator): Carbapenems-resistent Pseudomonas aeruginosa; 5.2 GLY (indicator): Vancomycin-resistents for Enterococcus faecium, and Enterococcus faecalis; 5.2.1 VR-EFM (sub-indicator): Vancomycin-resistant Enterococcus faecium; 5.2.2 VR-EFC (sub-indicator): Vancomycin-resistant Enterococcus faecalis; 5.3 BLA (indicator): β-lactams-resistants for multi-specises; 5.3.1 MR-SA (sub-indicator): Methicillin-resistant Staphylococcus aureus; 5.3.2 BR-KPN (sub-indicator): Third-generation β-lactams-resistent Klebsiella pneumoniae; 5.3.3 BR-ECO (sub-indicator): Third-generation β-lactams-resistent Escherichia coli; 5.3.4 BR-SPN (sub-indicator): Third-generation β-lactams-resistent Streptococcus pneumoniae; 5.3.5 BR-PAE (sub-indicator): Third-generation β-lactams-resistent Pseudomonas aeruginosa; 5.4 MAC (indicator): Macrolides-resistent for Streptococcus pneumoniae; 5.4.1 MR-SPN (sub-indicator): Macrolides-resistent Streptococcus pneumoniae; 5.5 AMI (indicator): Aminoglycosides-resistents for Klebsiella pneumoniae and Acinetobacter baumannii; 5.5.1 AR-KPN (sub-indicator): Aminoglycosides-resistent Klebsiella pneumoniae; 5.5.2AR-ABA (sub-indicator): Aminoglycosides-resistent Acinetobacter baumannii; 5.6 QUI (indicator): Quinolone-resistents for Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii; 5.6.1QNR-KPN (sub-indicator): Quinolone-resistant Klebsiella pneumoniae; 5.6.2QNR-ECO (sub-indicator): Quinolone-resistant Escherichia coli; 5.6.3QNR-ABA (sub-indicator): Quinolone-resistant Acinetobacter baumannii